Skip to main content
Erschienen in: Journal of Gastroenterology 9/2017

09.02.2017 | Original Article—Liver, Pancreas, and Biliary Tract

Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission

verfasst von: Tomoko Takano, Hitoshi Tajiri, Satoyo Hosono, Ayano Inui, Jun Murakami, Kosuke Ushijima, Yoko Miyoshi, Yuri Etani, Daiki Abukawa, Mitsuyoshi Suzuki, Stephen Brooks

Erschienen in: Journal of Gastroenterology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

It is necessary to evaluate the natural history of children with hepatitis B virus (HBV) infection in each country to consider their long-term management.

Methods

A multi-center observational study of children with chronic HBV infection who were diagnosed at age ≤15 years was carried out in 18 hospitals in Japan.

Results

We reviewed children with HBV infection including 381 with mother-to-child transmission (MTCT) and 154 with horizontal transmission, genotype C being the most prevalent virus genotype (83%). Children with horizontal transmission were more frequently infected with HBV genotype A or B and more likely to receive interferon therapy than those infected by MTCT. The HBeAg seroconversion rate at 15 years of age was 42% in the MTCT group and 38% in the horizontal group. It was lower in children with genotype C infection than in those infected with other genotypes (33 versus 45%). Hepatitis developed at any age but before 4 years of age the incidence was high in the horizontal group. At 3 years after the onset of the hepatitis, 26% of children with MTCT and 30% of those with horizontal transmission became inactive carriers. The incidences of hepatocellular carcinoma (HCC) at 30 years of age were 6% in the MTCT group and 11% in the horizontal group.

Conclusions

Patients with childhood-onset HBV infection with MTCT and horizontal transmission developed hepatitis and seroconverted to anti-HBe at any age and had a lifetime risk of developing HCC.
Literatur
1.
Zurück zum Zitat Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.CrossRefPubMed Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.CrossRefPubMed
2.
Zurück zum Zitat Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.CrossRefPubMed Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.CrossRefPubMed
3.
Zurück zum Zitat Koyama T, Matsuda I, Sato S, et al. Prevention of perinatal hepatitis B virus transmission by combined passive active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003;26:287–92.CrossRefPubMed Koyama T, Matsuda I, Sato S, et al. Prevention of perinatal hepatitis B virus transmission by combined passive active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003;26:287–92.CrossRefPubMed
4.
Zurück zum Zitat Tajiri H, Tanaka Y, Kagimoto S, et al. Molecular evidence of father-to-child transmission of hepatitis B virus. J Med Virol. 2007;79:922–6.CrossRefPubMed Tajiri H, Tanaka Y, Kagimoto S, et al. Molecular evidence of father-to-child transmission of hepatitis B virus. J Med Virol. 2007;79:922–6.CrossRefPubMed
5.
Zurück zum Zitat Aomatsu T, Komatsu H, Yoden A, et al. Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin’s lymphoma in an HBV carrier. Eur J Pediatr. 2010;169:167–71.CrossRefPubMed Aomatsu T, Komatsu H, Yoden A, et al. Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin’s lymphoma in an HBV carrier. Eur J Pediatr. 2010;169:167–71.CrossRefPubMed
6.
Zurück zum Zitat Sugauchi F, Orito E, Ohno T, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res. 2006;36:107–14.CrossRefPubMed Sugauchi F, Orito E, Ohno T, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res. 2006;36:107–14.CrossRefPubMed
7.
Zurück zum Zitat Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.CrossRefPubMed Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.CrossRefPubMed
8.
Zurück zum Zitat Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369–70.CrossRefPubMed Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369–70.CrossRefPubMed
9.
Zurück zum Zitat Lok AS. Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis. 1992;10:46–52.CrossRefPubMed Lok AS. Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis. 1992;10:46–52.CrossRefPubMed
11.
Zurück zum Zitat Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009;29:100–7.CrossRefPubMed Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009;29:100–7.CrossRefPubMed
12.
Zurück zum Zitat Della Corte C, Nobili V, Comparcola D, et al. Management of chronic hepatitis B in children: an unresolved issue. J Gastroenterol Hepatol. 2014;29:912–9.CrossRefPubMed Della Corte C, Nobili V, Comparcola D, et al. Management of chronic hepatitis B in children: an unresolved issue. J Gastroenterol Hepatol. 2014;29:912–9.CrossRefPubMed
13.
Zurück zum Zitat Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–7.CrossRefPubMed Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–7.CrossRefPubMed
14.
Zurück zum Zitat Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127:1733–8.CrossRefPubMed Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127:1733–8.CrossRefPubMed
15.
Zurück zum Zitat Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol. 2015;7:289–303.CrossRefPubMedPubMedCentral Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol. 2015;7:289–303.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5:1–9. Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5:1–9.
17.
Zurück zum Zitat Kimura A, Matsuyuki M, Yuge K, et al. Natural history of Japanese children with chronic hepatitis B: seroconversion from HBeAg to anti-HBe. Acta Paediatr Jpn. 1993;35:537–40.CrossRefPubMed Kimura A, Matsuyuki M, Yuge K, et al. Natural history of Japanese children with chronic hepatitis B: seroconversion from HBeAg to anti-HBe. Acta Paediatr Jpn. 1993;35:537–40.CrossRefPubMed
18.
Zurück zum Zitat Komatsu H, Inui A, Sogo T, et al. Chronic hepatitis B virus infection in children and adolescents in Japan. J Pediatr Gastroenterol Nutr. 2015;60:99–104.CrossRefPubMed Komatsu H, Inui A, Sogo T, et al. Chronic hepatitis B virus infection in children and adolescents in Japan. J Pediatr Gastroenterol Nutr. 2015;60:99–104.CrossRefPubMed
19.
Zurück zum Zitat Takano T, Tajiri H, Etani Y, et al. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy. Scand J Gastroenterol. 2015;50:892–9.CrossRefPubMed Takano T, Tajiri H, Etani Y, et al. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy. Scand J Gastroenterol. 2015;50:892–9.CrossRefPubMed
20.
Zurück zum Zitat Popalis C, Yeung LT, Ling SC, et al. Chronic hepatitis B virus (HBV) infection in children: 25 years’ experience. J Viral Hepat. 2013;20:e20–6.CrossRefPubMed Popalis C, Yeung LT, Ling SC, et al. Chronic hepatitis B virus (HBV) infection in children: 25 years’ experience. J Viral Hepat. 2013;20:e20–6.CrossRefPubMed
21.
Zurück zum Zitat Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years’ follow-up in northern Greece. J Pediatr Gastroenterol Nutr. 2007;44:84–91.CrossRefPubMed Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years’ follow-up in northern Greece. J Pediatr Gastroenterol Nutr. 2007;44:84–91.CrossRefPubMed
22.
Zurück zum Zitat Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology. 2010;52:2192–205.CrossRefPubMed Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology. 2010;52:2192–205.CrossRefPubMed
23.
Zurück zum Zitat Sugauchi S, Mizokami M, Orito E, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol. 2001;82:883–92.CrossRefPubMed Sugauchi S, Mizokami M, Orito E, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol. 2001;82:883–92.CrossRefPubMed
24.
Zurück zum Zitat Sugauchi F, Orito E, Ichida T, et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol. 2002;76:5985–92.CrossRefPubMedPubMedCentral Sugauchi F, Orito E, Ichida T, et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol. 2002;76:5985–92.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat le Lee Y, Aw M, Rauff M, et al. Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children. J Med Virol. 2015;87:1344–50.CrossRefPubMed le Lee Y, Aw M, Rauff M, et al. Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children. J Med Virol. 2015;87:1344–50.CrossRefPubMed
26.
Zurück zum Zitat Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19:e18–25.CrossRefPubMed Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19:e18–25.CrossRefPubMed
27.
Zurück zum Zitat Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat. 2007;14:147–52.CrossRefPubMed Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat. 2007;14:147–52.CrossRefPubMed
28.
Zurück zum Zitat Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118:554–9.CrossRefPubMed Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118:554–9.CrossRefPubMed
29.
Zurück zum Zitat Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.CrossRefPubMed Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.CrossRefPubMed
Metadaten
Titel
Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission
verfasst von
Tomoko Takano
Hitoshi Tajiri
Satoyo Hosono
Ayano Inui
Jun Murakami
Kosuke Ushijima
Yoko Miyoshi
Yuri Etani
Daiki Abukawa
Mitsuyoshi Suzuki
Stephen Brooks
Publikationsdatum
09.02.2017
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 9/2017
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-017-1315-4

Weitere Artikel der Ausgabe 9/2017

Journal of Gastroenterology 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.